Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report

Gefitnib is an oral agent of epidermal growth factor receptor tyrosine kinase inhibitor, and it has a certain efficacy against non-small cell lung cancer. There are some reports that the non-small cell lung cancer patients who experienced disease progression after responding to gefitinib were again...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Jin, Lee, Ho Sung, Choi, Jae Sung, Na, Ju Ock, Seo, Ki Hyun, Oh, Mi Hye, Jou, Sung Shick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376882/
https://www.ncbi.nlm.nih.gov/pubmed/22719810
http://dx.doi.org/10.4021/jocmr816e
_version_ 1782235889269735424
author Lee, Su Jin
Lee, Ho Sung
Choi, Jae Sung
Na, Ju Ock
Seo, Ki Hyun
Oh, Mi Hye
Jou, Sung Shick
author_facet Lee, Su Jin
Lee, Ho Sung
Choi, Jae Sung
Na, Ju Ock
Seo, Ki Hyun
Oh, Mi Hye
Jou, Sung Shick
author_sort Lee, Su Jin
collection PubMed
description Gefitnib is an oral agent of epidermal growth factor receptor tyrosine kinase inhibitor, and it has a certain efficacy against non-small cell lung cancer. There are some reports that the non-small cell lung cancer patients who experienced disease progression after responding to gefitinib were again sensitive to re-administration of gefitinib following temporary cessation of gefitinib. This is the case report showing a remarkable effect of gefitinib re-treatment in a patient with metastatic invasive adenocarinoma who had experienced favorable results from the initial treatment with gefitinib.
format Online
Article
Text
id pubmed-3376882
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-33768822012-06-20 Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report Lee, Su Jin Lee, Ho Sung Choi, Jae Sung Na, Ju Ock Seo, Ki Hyun Oh, Mi Hye Jou, Sung Shick J Clin Med Res Case Report Gefitnib is an oral agent of epidermal growth factor receptor tyrosine kinase inhibitor, and it has a certain efficacy against non-small cell lung cancer. There are some reports that the non-small cell lung cancer patients who experienced disease progression after responding to gefitinib were again sensitive to re-administration of gefitinib following temporary cessation of gefitinib. This is the case report showing a remarkable effect of gefitinib re-treatment in a patient with metastatic invasive adenocarinoma who had experienced favorable results from the initial treatment with gefitinib. Elmer Press 2012-06 2012-05-15 /pmc/articles/PMC3376882/ /pubmed/22719810 http://dx.doi.org/10.4021/jocmr816e Text en Copyright 2012, Lee et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Lee, Su Jin
Lee, Ho Sung
Choi, Jae Sung
Na, Ju Ock
Seo, Ki Hyun
Oh, Mi Hye
Jou, Sung Shick
Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report
title Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report
title_full Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report
title_fullStr Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report
title_full_unstemmed Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report
title_short Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report
title_sort remarkable effect of gefitinib retreatment in a lung cancer patient with lepidic predominat adenocarcinoma who had experienced favorable results from initial treatment with gefitinib: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376882/
https://www.ncbi.nlm.nih.gov/pubmed/22719810
http://dx.doi.org/10.4021/jocmr816e
work_keys_str_mv AT leesujin remarkableeffectofgefitinibretreatmentinalungcancerpatientwithlepidicpredominatadenocarcinomawhohadexperiencedfavorableresultsfrominitialtreatmentwithgefitinibacasereport
AT leehosung remarkableeffectofgefitinibretreatmentinalungcancerpatientwithlepidicpredominatadenocarcinomawhohadexperiencedfavorableresultsfrominitialtreatmentwithgefitinibacasereport
AT choijaesung remarkableeffectofgefitinibretreatmentinalungcancerpatientwithlepidicpredominatadenocarcinomawhohadexperiencedfavorableresultsfrominitialtreatmentwithgefitinibacasereport
AT najuock remarkableeffectofgefitinibretreatmentinalungcancerpatientwithlepidicpredominatadenocarcinomawhohadexperiencedfavorableresultsfrominitialtreatmentwithgefitinibacasereport
AT seokihyun remarkableeffectofgefitinibretreatmentinalungcancerpatientwithlepidicpredominatadenocarcinomawhohadexperiencedfavorableresultsfrominitialtreatmentwithgefitinibacasereport
AT ohmihye remarkableeffectofgefitinibretreatmentinalungcancerpatientwithlepidicpredominatadenocarcinomawhohadexperiencedfavorableresultsfrominitialtreatmentwithgefitinibacasereport
AT jousungshick remarkableeffectofgefitinibretreatmentinalungcancerpatientwithlepidicpredominatadenocarcinomawhohadexperiencedfavorableresultsfrominitialtreatmentwithgefitinibacasereport

Ejemplares similares